Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 1
2(100.0%)
2Total
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04375436Phase 1Completed

Safety and Tolerability of NTRX-07 in Healthy Volunteers

Role: collaborator

NCT03290248Phase 1Completed

Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 in Healthy Volunteers and Subjects With Seasonal Allergic Rhinitis

Role: collaborator

NCT04685733Completed

Caretaker Hemodynamic Parameters Validation

Role: collaborator

NCT03232437Completed

Reproducibility of HbA1c Measurement on the Aina HbA1c Monitoring System

Role: collaborator

All 4 trials loaded